ACOR Annual Total Expenses
$140.90 M
-$19.70 M-12.27%
31 December 2023
Summary:
As of February 3, 2025, ACOR annual total expenses is $140.90 million, with the most recent change of -$19.70 million (-12.27%) on December 31, 2023. During the last 3 years, it has fallen by -$98.97 million (-41.26%).ACOR Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACOR Quarterly Total Expenses
$33.68 M
-$2.83 M-7.75%
31 March 2024
Summary:
As of February 3, 2025, ACOR quarterly total expenses is $33.68 million, with the most recent change of -$2.83 million (-7.75%) on March 31, 2024. Over the past year, it has dropped by -$1.15 million (-3.30%).ACOR Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACOR Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.3% | -3.3% |
| 3 y3 years | -41.3% | -42.3% |
| 5 y5 years | -62.7% | -58.0% |
ACOR Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -74.2% | -76.5% |
Acorda Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $33.68 M(-7.7%) |
| Dec 2023 | $140.90 M(-12.3%) | $36.50 M(+3.0%) |
| Sept 2023 | - | $35.44 M(+3.8%) |
| June 2023 | - | $34.13 M(-2.0%) |
| Mar 2023 | - | $34.83 M(+28.3%) |
| Dec 2022 | $160.60 M(-22.2%) | $27.15 M(-37.0%) |
| Sept 2022 | - | $43.08 M(-10.4%) |
| June 2022 | - | $48.08 M(+13.7%) |
| Mar 2022 | - | $42.29 M(+1.4%) |
| Dec 2021 | $206.37 M(-14.0%) | $41.70 M(-20.7%) |
| Sept 2021 | - | $52.55 M(-2.2%) |
| June 2021 | - | $53.76 M(-7.9%) |
| Mar 2021 | - | $58.37 M(+4.7%) |
| Dec 2020 | $239.86 M(-23.5%) | $55.73 M(-14.9%) |
| Sept 2020 | - | $65.53 M(+12.5%) |
| June 2020 | - | $58.26 M(-3.5%) |
| Mar 2020 | - | $60.35 M(-9.4%) |
| Dec 2019 | $313.41 M(-17.1%) | $66.60 M(-17.2%) |
| Sept 2019 | - | $80.45 M(-6.7%) |
| June 2019 | - | $86.24 M(+7.6%) |
| Mar 2019 | - | $80.12 M(-6.1%) |
| Dec 2018 | $377.95 M(-21.8%) | $85.35 M(-7.0%) |
| Sept 2018 | - | $91.82 M(-9.3%) |
| June 2018 | - | $101.27 M(+1.8%) |
| Mar 2018 | - | $99.51 M(-20.4%) |
| Dec 2017 | $483.44 M(-11.6%) | $125.06 M(+20.0%) |
| Sept 2017 | - | $104.18 M(-20.1%) |
| June 2017 | - | $130.34 M(+5.2%) |
| Mar 2017 | - | $123.86 M(-13.5%) |
| Dec 2016 | $546.98 M(+22.2%) | $143.21 M(+4.2%) |
| Sept 2016 | - | $137.38 M(-1.5%) |
| June 2016 | - | $139.49 M(+9.9%) |
| Mar 2016 | - | $126.89 M(+2.7%) |
| Dec 2015 | $447.77 M(+25.8%) | $123.53 M(+3.5%) |
| Sept 2015 | - | $119.31 M(+11.6%) |
| June 2015 | - | $106.92 M(+9.1%) |
| Mar 2015 | - | $98.01 M(-8.8%) |
| Dec 2014 | $355.90 M | $107.51 M(+26.3%) |
| Sept 2014 | - | $85.13 M(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $86.15 M(+11.7%) |
| Mar 2014 | - | $77.10 M(-3.4%) |
| Dec 2013 | $306.06 M(+9.2%) | $79.84 M(+8.6%) |
| Sept 2013 | - | $73.55 M(-6.1%) |
| June 2013 | - | $78.31 M(+5.3%) |
| Mar 2013 | - | $74.36 M(-7.2%) |
| Dec 2012 | $280.21 M(+9.0%) | $80.15 M(+19.5%) |
| Sept 2012 | - | $67.07 M(-5.0%) |
| June 2012 | - | $70.60 M(+13.2%) |
| Mar 2012 | - | $62.39 M(+4.7%) |
| Dec 2011 | $257.18 M(+29.0%) | $59.62 M(-17.6%) |
| Sept 2011 | - | $72.36 M(+12.4%) |
| June 2011 | - | $64.36 M(+5.8%) |
| Mar 2011 | - | $60.84 M(-2.9%) |
| Dec 2010 | $199.44 M(+46.7%) | $62.68 M(+24.5%) |
| Sept 2010 | - | $50.36 M(+3.7%) |
| June 2010 | - | $48.54 M(+28.2%) |
| Mar 2010 | - | $37.85 M(+3.8%) |
| Dec 2009 | $135.93 M(+12.1%) | $36.47 M(+6.6%) |
| Sept 2009 | - | $34.22 M(-1.5%) |
| June 2009 | - | $34.74 M(+13.9%) |
| Mar 2009 | - | $30.50 M(-8.3%) |
| Dec 2008 | $121.27 M(+53.6%) | $33.25 M(+4.8%) |
| Sept 2008 | - | $31.72 M(+11.5%) |
| June 2008 | - | $28.46 M(+2.2%) |
| Mar 2008 | - | $27.84 M(+8.0%) |
| Dec 2007 | $78.93 M(+55.3%) | $25.78 M(+32.7%) |
| Sept 2007 | - | $19.42 M(+10.3%) |
| June 2007 | - | $17.61 M(+9.2%) |
| Mar 2007 | - | $16.12 M(+11.4%) |
| Dec 2006 | $50.82 M(+28.5%) | $14.47 M(+11.5%) |
| Sept 2006 | - | $12.98 M(+6.3%) |
| June 2006 | - | $12.21 M(+9.4%) |
| Mar 2006 | - | $11.16 M(-4.1%) |
| Dec 2005 | $39.55 M(-12.6%) | $11.63 M(+17.4%) |
| Sept 2005 | - | $9.91 M(-58.2%) |
| Dec 2004 | $45.25 M(-28.6%) | - |
| Dec 2003 | $63.34 M(+133.4%) | - |
| Sept 2003 | - | $23.71 M |
| June 2003 | $27.14 M | - |
FAQ
- What is Acorda Therapeutics annual total expenses?
- What is the all time high annual total expenses for Acorda Therapeutics?
- What is Acorda Therapeutics annual total expenses year-on-year change?
- What is Acorda Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly total expenses year-on-year change?
What is Acorda Therapeutics annual total expenses?
The current annual total expenses of ACOR is $140.90 M
What is the all time high annual total expenses for Acorda Therapeutics?
Acorda Therapeutics all-time high annual total expenses is $546.98 M
What is Acorda Therapeutics annual total expenses year-on-year change?
Over the past year, ACOR annual total expenses has changed by -$19.70 M (-12.27%)
What is Acorda Therapeutics quarterly total expenses?
The current quarterly total expenses of ACOR is $33.68 M
What is the all time high quarterly total expenses for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly total expenses is $143.21 M
What is Acorda Therapeutics quarterly total expenses year-on-year change?
Over the past year, ACOR quarterly total expenses has changed by -$1.15 M (-3.30%)